While IndyCar races have traditionally been held within the United States (with an annual jaunt to Canada), the growing profile of American open-wheel racing has sparked plenty of interest for an ...

Ahead of its on-screen debut during the Super Bowl, Fox released its latest ad from it's IndyCar promo campaign featuring fan-favorite Pato O'Ward. Mike Woodson to step down as Indiana basketball ...

Earlier this offseason, Pato O'Ward, IndyCar's most popular driver, finally found himself on a billboard. And now he can say he's starred in a Super Bowl commercial about to be seen by more than ...

Alex Palou makes a moving wish for teammate Scott Dixon in 2025 Indy 500 prediction 'Unbeatable' Alex Palou compared to Max Verstappen in bold claim by IndyCar insider 'Unbeatable' Alex Palou ...

In this video, I will go over Novo Nordisk's (NVO-3.62%) and Eli Lilly's recent earnings report. Watch the short video to learn more, consider subscribing, and click the special offer link below.

In this article, we are going to take a look at where Novo Nordisk A/S (NYSE:NVO) stands against the other stocks. Ken Fisher is the founder and executive chairman of Fisher Asset Management ...

Trading in Novo Nordisk shares by board members, executives and associated persons Bagsværd, Denmark, 7 February 2025 — This company announcement discloses the data of the transaction(s ...

Led by racing legend Michael Andretti, Andretti Global fields multiple entries in INDYCAR, INDY NXT, IMSA and Formula E and has collaborations in Extreme E as Andretti Altawkilat Extreme E, Mexico ...

Note: This continues a series of 2025 NTT INDYCAR SERIES team previews on INDYCAR.com. The season starts Sunday, March 2 with the Firestone Grand Prix of St. Petersburg presented by RP Funding (noon ...

Novo Nordisk’s annual results are out and they show the Danish pharmaceutical juggernaut earnt 290.4 billion Danish kroner last year (A$64 billion) — up 25%. Novo Nordisk boasts 45 million ...

Less-than-stellar phase 3 results with Novo Nordisk's highly anticipated obesity therapy CagriSema have caused its shares to fall by over a fifth, wiping around $94 billion off its market cap.